Skip to main content
OpenTrials
Completed

NCT Number: NCT04198961

Electronic Intervention to Chronic Opioid Therapy

This pilot study will attempt to apply an electronic chart intervention to improve safety for patients on chronic opioid medications.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Opioid Therapy

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Stanford University

Stanford, California, 94305, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients prescribed long-term opioid therapy of doses greater than 90 morphine equivalent daily dose (MEDD)

Exclusion criteria

  • Patients prescribed short-term opioid medications for acute pain (less than a 90-day supply over the past 120 days), sublingual buprenorphine, methadone maintenance for opioid use disorder or with oncology or palliative care diagnoses will be excluded.

Treatment and study plan

opioid prescribing

Other

Individualized taper and safety recommendations will be communicated to prescribers via an electronic medical record encrypted message.

Primary outcomes

  1. Change in the number of patients who receives naloxone prescription

    Time frame: baseline, 1, 3- and 6-months and 12 months

    Change in the number of patients who receives naloxone prescription

  2. change of number of documentation about safety discussions

    Time frame: baseline, 1, 3- and 6-months and 12 months

    change of number of documentation about safety discussions

  3. change of number of order for urine toxicology screening

    Time frame: baseline, 1, 3- and 6-months and 12 months

    change of number of order for urine toxicology screening

  4. change of number of documentation of prescription drug monitoring program (CURES) results

    Time frame: baseline, 1, 3- and 6-months and 12 months

    change of number of documentation of prescription drug monitoring program (CURES) results

  5. change of number of signed opioid informed consent forms

    Time frame: baseline, 1, 3- and 6-months and 12 months

    change of number of signed opioid informed consent forms

Secondary outcomes

  1. Change in number of patients on long-term high risk doses of opioid pain medications

    Time frame: baseline, 1, 3- and 6-months and 12 months

    decreases in daily dose of opioids and number of patients on opioids ≥ 90mg MEDD

Sponsors and collaborators

Lead sponsor

Stanford University

Other

Registry information

Official study title

An Electronic Chart Intervention to Improve Safety for Patients on Chronic Opioid Therapy

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Dec 13, 2019
Registry last updated
Nov 9, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.